N&M PHARMA
Business purpose.
La détention de parts ou d'actions de sociétés visées au premier alinéa de l'article 1 de la loi n90-1258 du 31 décembre 1990, dont l'objet est l'exercice de la profession de pharmacien d'officine, la participation à tout groupement de droit étranger ayant pour objet l'exercice de la profession de pharmacien d'officine, et toutes activités accessoires en relation directe avec leur objet et destinées exclusivement aux sociétés ou aux groupements dont elle détient les participations.
Identity
- Legal form
- SPFPL holding company for regulated professions, as an SAS (SPFPL SAS)
- Activity
- Dispensing chemist in specialised stores (47.73Z)
- Sector
- Retail trade, except of motor vehicles and motorcycles
- Headcount
- Headcount unknown
- Created
- 1 Jan 2023
- Share capital
- 10,000.00 EUR
- Registered with the trade register
- 27 Oct 2022
- Financial year end
- 30/09
- Establishments
- 2
Directors
- AURORE CHRISTINE BAUDINO 42 years old, 08/1984 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- SELARL MEN AR PIC via AURORE CHRISTINE BAUDINO
Establishments
-
92090744100017 29830 PLOUDALMEZEAU
Financial strength
Financial score
66 / 100 B
Confidence: medium · computed on the financial year ended 30 Sep 2025
- Equity to assets (79.6 %)
- 26.5 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (586.7 %)
- 16.3 out of 20
- Debt (696.5 %)
- 0.0 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
88 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (3.8 years)
- 7.6 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 30 Sep 2025 | 0 € | — | -5,001 € | 49,006 € |
| 30 Jun 2023 | 0 € | first year on record | -6,846 € | 66,727 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Legal notices
-
Filing of accounts 28 Apr 2026
- Court :
- Greffe du Tribunal de Commerce de brest
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/09/2025
BODACC C n 20260081, annonce n 2019 · Proof of publication (PDF)
-
Filing of accounts 20 Feb 2024
- Court :
- Greffe du Tribunal de Commerce de brest
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 30/06/2023
BODACC C n 20240035, annonce n 1754 · Proof of publication (PDF)
Filings and accounts
- Formality 28 Jul 2025
Change history
- officer_appointed (empty) → President de SAS 9 Oct 2026
Frequently asked questions about N&M PHARMA
- What is the SIREN number of N&M PHARMA?
- The SIREN number of N&M PHARMA is 920907441. Its intra-community VAT number is FR54920907441.
- Where is the head office of N&M PHARMA?
- Head office address: 9 CHEMIN DES HIBISCUS, 29830 PLOUDALMEZEAU.
- When was N&M PHARMA founded?
- N&M PHARMA was founded on 1 Jan 2023.
- What does N&M PHARMA do?
- Its declared main activity is: Dispensing chemist in specialised stores (NAF code 47.73Z).
- Who runs N&M PHARMA?
- The officer listed in the register is AURORE CHRISTINE BAUDINO (President de SAS).
- What is the revenue of N&M PHARMA?
- The latest published revenue is 0 €, for the 2025 financial year.
- Is N&M PHARMA subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.